Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aditxt, Inc. (ADTX)
NASDAQ:ADTX
Holding ADTX?
Track your performance easily
ADTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $218.06
Previous Close$0.18
Volume28.68M
Average Volume (3M)26.39M
Market Cap
$1.96M
Enterprise ValueN/A
Total Cash (Recent Filing)$25.00K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.45
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-981.65
Shares Outstanding14,234,210
10 Day Avg. Volume68,915,296
30 Day Avg. Volume26,388,553
Standard Deviation0.47
R-Squared0.01
Alpha-0.16
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.23
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aditxt, Inc. News
PremiumCompany Announcements
Aditxt, Inc. Plans IPO for Pearsanta in 2025PremiumCompany Announcements
Aditxt Advances ADI-100 Therapy to Human Trials
PremiumCompany Announcements
Aditxt, Inc. Focuses on Growth Amid Nasdaq Compliance
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ADTX FAQ
What was Aditxt, Inc.’s price range in the past 12 months?
Aditxt, Inc. lowest stock price was $0.12 and its highest was $218.06 in the past 12 months.
What is Aditxt, Inc.’s market cap?
Aditxt, Inc.’s market cap is $1.96M.
When is Aditxt, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aditxt, Inc.’s earnings last quarter?
Currently, no data Available
Is Aditxt, Inc. overvalued?
According to Wall Street analysts Aditxt, Inc.’s price is currently Overvalued.
Does Aditxt, Inc. pay dividends?
Aditxt, Inc. does not currently pay dividends.
What is Aditxt, Inc.’s EPS estimate?
Aditxt, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aditxt, Inc. have?
Aditxt, Inc. has 14,234,210 shares outstanding.
What happened to Aditxt, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aditxt, Inc.?
Currently, no hedge funds are holding shares in ADTX
---
Company Description
Aditxt, Inc.
ADiTx Therapeutics Inc is a pre-clinical stage, life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.
---
Technical Analysis
---